EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, PT Kimia Farma Tbk's enterprise value is $1,014.46 Mil.
PT Kimia Farma Tbk's Revenue for the trailing twelve months (TTM) ended in Jun. 2024 was $662.47 Mil. Therefore, PT Kimia Farma Tbk's EV-to-Revenue for today is 1.53.
The historical rank and industry rank for PT Kimia Farma Tbk's EV-to-Revenue or its related term are showing as below:
PTKMF'
s EV-to-Revenue Range Over the Past 10 Years
Min: 0.76 Med: 1.63 Max: 3.8
Current: 1.1
During the past 13 years, the highest EV-to-Revenue of PT Kimia Farma Tbk was 3.80. The lowest was 0.76. And the median was 1.63.
PTKMF's EV-to-Revenue is ranked worse than 63.73% of 102
companies
in the Medical Distribution industry
Industry Median: 0.64
vs PTKMF: 1.10
The historical data trend for PT Kimia Farma Tbk's EV-to-Revenue can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of PT Kimia Farma Tbk's EV-to-Revenue
For the Medical Distribution subindustry, PT Kimia Farma Tbk's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
PT Kimia Farma Tbk's EV-to-Revenue Distribution in the Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, PT Kimia Farma Tbk's EV-to-Revenue distribution charts can be found below:
* The bar in red indicates where PT Kimia Farma Tbk's EV-to-Revenue falls into.
PT Kimia Farma Tbk's current Enterprise Value is $1,014.46 Mil.
PT Kimia Farma Tbk's Revenue for the trailing twelve months (TTM) ended in Jun. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $662.47 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PT Kimia Farma Tbk (GREY:PTKMF) EV-to-Revenue Explanation
PT Kimia Farma Tbk's share price for today is $0.00.
PT Kimia Farma Tbk's Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.12.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PT Kimia Farma Tbk EV-to-Revenue Related Terms
Thank you for viewing the detailed overview of PT Kimia Farma Tbk's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.
PT Kimia Farma Tbk is an Indonesia based company engaged in the production and distribution of healthcare products. It operates through the following segments: Manufacture, Distribution, Retail, and Others. The company provides its products in three categories including Ethical, Generic and others. Some of its product offerings include Topgesic, Protofen, Neurodial, Omeprazole, Antalgin, Pethidine, Salicylfresh and Doveri. It generates maximum revenue from the retail segment.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
PTKMF has been successfully added to your 